Načítá se...
Beyond Monoamines-Novel Targets for Treatment-Resistant Depression: A Comprehensive Review
Major depressive disorder (MDD) is a leading cause of disability worldwide. Current first line therapies target modulation of the monoamine system. A large variety of agents are currently available that effectively alter monoamine levels; however, approximately one third of MDD patients remain treat...
Uloženo v:
| Vydáno v: | Curr Neuropharmacol |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Bentham Science Publishers
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4761634/ https://ncbi.nlm.nih.gov/pubmed/26467412 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1570159X13666150630175044 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|